Presentation TCT 2020 The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome Presenter: Hyo-Soo Kim October 17, 2020
Presentation Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents February 13, 2017
Presentation Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI Presenter: T. Palmerini June 04, 2013
Presentation TCT 2013 The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman January 31, 2013
Presentation TCT 2012 Frequency and Predictors of Drug Eluting Stents Implantation in Patients with Acute Myocardial Infarction - Analysis from the PL-ACS Registry. Presenter: Marek Gierlotka, Mariusz Gasior, Michal Hawranek, Zbigniew Kalarus, Pawel Buszman, Jacek Legutko, Andrzej Lekston, Lech Polonski January 03, 2012